We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgery Advised for Severely Narrowed Iliac Arteries

By HospiMedica International staff writers
Posted on 26 Aug 2013
A new study suggests that surgery is the best option for aortoiliac occlusive disease (AIOD), a disorder of the circulatory system that occurs when the iliac arteries narrow or become blocked.

Researchers at Yale University School of Medicine (Yale, New Haven, CT, USA) and McMaster University (Hamilton, Canada) systematically searched studies on open and endovascular treatment for AIOD published from 1989 to 2010, identifying 29 open bypass studies involving 3,733 patients, and 28 endovascular treatment studies involving 1,625 patients. More...
Assuming between-study heterogeneity due to bias inherent to observational studies, a random effects model was used for calculation of weighted proportions.

The results showed that poor preoperative runoff was greater in the open bypass group. Mean length of hospital stay was 13 days for open bypass, compared to 4 days for endovascular treatment procedures. The open bypass group also experienced more complications and greater 30-day mortality. On the other hand, at 1, 3, and 5 years, primary patency rates were greater in the open bypass group than the endovascular cohort; the same was true for secondary patency. The study was published in the August 2013 issue of the Journal of Endovascular Therapy.

“There is a trend to higher complication rates in direct open repair compared to endovascular repair based on our review, but the complication rate following endovascular procedures is higher than that previously reported,” concluded lead author Jeffrey Indes, MD, of Yale, and colleagues. “Direct open repair still remains the more durable option and should be offered to patients who are suitable and able to withstand the rigors of laparotomy. Endovascular repair is a viable alternative and perhaps an appropriate first-line treatment in certain patients.”

AIO is an atherosclerotic occlusive disease involving the abdominal aorta and/or both of the iliac arteries. Classically, it is described in male patients as a triad of symptoms consisting of claudication of the buttocks and thighs, absent or decreased femoral pulses, and impotence, a combination known as Leriche syndrome. However, any number of symptoms may present, depending on the distribution and severity of the disease, such as muscle atrophy and slow wound healing in the legs.

Related Links:

Yale University School of Medicine
McMaster University



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.